Crohn’s Disease (CD) is considered a result of multifactorial interplay between genetic, immune-related, environmental, and infectious triggers all contributing into evolution of clinical disease.
The age of onset of Crohn’s disease has a bimodal distribution. The first peak occurs between the ages of 15 and 30 years (late adolescence and early adulthood), and the second occurs mainly in women between the ages of 60 and 70 years.
In general, the frequency of CD is similar in males and females, with some studies showing a very slight female predominance.
The rate of Crohn’s disease is 1.1–1.8 times higher in women than in men. This pattern is reversed with pediatric CD, which has a higher incidence in boys than in girls (pediatric male-to-female ratio, ~1.6:1).
- Measle Vaccine
- Annual Incidence Rate
- IL23R Gene
- Slight Female Predominance
- Infectious Trigger
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Tax calculation will be finalised at checkout
Purchases are for personal use onlyLearn about institutional subscriptions
Duerr RH. Update on the genetics of inflammatory bowel disease. J Clin Gastroenterol. 2003;37(5):358–67.
Gaya DR, Russell RK, Nimmo ER, et al. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet. 2006;367:1271–84.
Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time. Based on systematic review. Gastroenterology. 2012;142:46–54.
Binder V. Epidemiology of I BD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol. 2004;18:463–79.
Hovde Ø, Moum BA. Epidemiology and clinical course of Crohn’s disease: results from observational studies. World J Gastroenterol. 2012;18(15):1723–31.
Jess T, Loftus Jr EV, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut. 2006;55:1248–54.
Ogunbi SO, Ransom JA, Sullivan K, et al. Inflammatory bowel disease in African-American children living in Georgia. J Pediatr. 1998;133:103–7.
Mendelhoff AI, Calkin BM. The epidemiology of inflammatory bowel disease. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. 3rd ed. Philadelphia: Lea and Febriger; 1988. p. 3–34.
Depew WT. Clinical presentation and course of Crohn’s disease in south-eastern Ontario. Can J Gastroenterol. 1988;2:107–16.
Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis. 2004;10:106–11.
Linares de la Cal JA, Canton C, Pajares JM, et al. Inflammatory bowel disease in Argentina and Panama (1987-1993). Eur J Gastroenterol Hepatol. 1997;9:1129.
Figueroa CC, Quera PR, Valenzuela EJ, et al. Inflammatory bowel disease: experience of two Chilean centers. Rev Med Chil. 2005;133:1295–304.
Souza MH, Troncon LE, Rodrigues CM, et al. T rends in the occurrence (1980-1999) and clinical features of Crohn’s disease and ulcerative colitis in a university hospital in southeastern Brazil. Arq Gastroenterol. 2002;39:98–105.
Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (ECIBD). Gut. 1996;39:690–7.
Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100:350–8.
Moum B, Vatn MH, Ekbom A, et al. Incidence of Crohn’s disease in four counties in southeastern Norway, 1990-93. A prospective population- based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:355–61.
Sepp E, Julge K, Vasar M, et al. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr. 1997;86:956–61.
Armitage EL, Aldhous MC, Anderson N, et al. Incidence of juvenile-onset Crohn’s disease in Scotland: association with northern latitude and affluence. Gastroenterology. 2004;127(4):1051–7.
Fellows IW, Freeman JG, Holmes GK. Crohn’s disease in the city of Derby, 1951-85. Gut. 1990;31:1262–5.
Economou M, Zambeli E, Michopoulos S, et al. Incidence and prevalence of Crohn’s disease and its etiological influences. Ann Gastroenterol. 2009;22(3):158–67.
Mate-Jimenez J, Munoz S, Vicent D, et al. Incidence and prevalence of ulcerative colitis and Crohn’s disease in urban and rural areas of Spain from 1981 to 1988. J Clin Gastroenterol. 1994;18:27–31.
Di Domenicantonio R, Cappai G, Arcà M, et al. Occurrence of inflammatory bowel disease in central Italy: a study based on health information systems. Dig Liver Dis. 2014;46:777–82.
Economou M, Filis G, Tsianou Z, et al. Crohn’s disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants. World J Gastroenterol. 2007;13:5116–20.
Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010;11:134–47.
Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am. 2007;87(3):575–85.
Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. Lancet. 2002;359(9318):1661–5.
Glas J, Seiderer J, Wetzke M, et al. rs1004819 is the main disease-associated IL23R variant in German Crohn’s disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One. 2007;2(9):e819.
Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40(8):955–62.
Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39(2):207–11.
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.
Sandborn WJ, Hanauer SB, Rutgeerts P, et al. Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial. Gut. 2007;56(9):1232–9).
Lindberg E, Järnerot G, Huitfeldt B. Smoking in Crohn’s disease: effect on localisation and clinical course. Gut. 1992;33(6):779–82.
D’Souza S, Levy E, Mack D, Israel D, Lambrette P, Ghadirian P. Dietary patterns and risk for Crohn’s disease in children. Inflamm Bowel Dis. 2008;14(3):367–73.
Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med. 2001;155(3):354–9.
Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J. The risk of developing Crohn’s disease after an appendectomy: a meta-analysis. Am J Gastroenterol. 2008;103:2925–31.
Editors and Affiliations
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vitale, F. (2016). Epidemiological Aspects of Crohn’s Disease. In: Lo Re, G., Midiri, M. (eds) Crohn’s Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-23066-5_1
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23065-8
Online ISBN: 978-3-319-23066-5